Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 31;13(4):343-351.
doi: 10.18683/germs.2023.1404. eCollection 2023 Dec.

Endophthalmitis caused by Enterococcus casseliflavus: a systematic review of literature

Affiliations
Review

Endophthalmitis caused by Enterococcus casseliflavus: a systematic review of literature

Stylianos A Kandarakis et al. Germs. .

Abstract

Introduction: Enterococcus casseliflavus is a rare pathogen in human infections, despite being widely distributed in natural environments. This systematic review aims to evaluate the evidence related to endophthalmitis caused by E. casseliflavus.

Methods: A thorough search of PubMed, PubMed Central, and Scopus databases was conducted, covering the period up to October 2022.

Results: A total of 53 records were identified, with 8 studies reporting a total of 21 cases meeting the inclusion criteria. Among these studies, 7 described isolated case reports, while 1 study described 14 cases. The overall quality of the reports was good, as all articles were determined to have low risk of bias. Vancomycin susceptibility was reported in only one case of isolated case reports, while the remaining cases were all vancomycin resistant. With regard to management, in most cases intravenous ampicillin and linezolid were administered, while only one study reported administration of vancomycin.

Conclusions: Ophthalmologists should be aware of the potential for E. casseliflavus to cause endophthalmitis infections and the challenges associated with its intrinsic resistance to vancomycin.

Keywords: Enterococcus casseliflavus; endophthalmitis; resistance; systematic review; vancomycin.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: All authors – none to declare.

Figures

Figure 1.
Figure 1.. PRISMA flow diagram of articles related to Enterococcus casseliflavus endophthalmitis case reports

References

    1. Monticelli J, Knezevich A, Luzzati R, Di Bella S. Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens. J Infect Chemother. 2018;24:237–46. doi: 10.1016/j.jiac.2018.01.001. - DOI - PubMed
    1. Mundt JO, Graham WF. Streptococcus faecium var. casselifavus, nov. var. J Bacteriol. 1968;95:2005–9. doi: 10.1128/jb.95.6.2005-2009.1968. - DOI - PMC - PubMed
    1. Britt NS, Potter EM. Clinical epidemiology of vancomycin-resistant Enterococcus gallinarum and Enterococcus casseliflavus bloodstream infections. J Glob Antimicrob Resist. 2016;5:57–61. doi: 10.1016/j.jgar.2015.12.002. - DOI - PMC - PubMed
    1. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:1–17. doi: 10.1016/S0002-9394(14)71959-2. - DOI - PubMed
    1. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71. - DOI - PMC - PubMed

LinkOut - more resources